Key result
PTCA and CABG achieve high procedural success with low complication rates in elderly patients.
Why the study?
Aging influences lifespan and treatment outcomes in elderly patients with angina, but effective therapies are often underused despite evidence of similar mortality reductions and successful interventions.
Chronological age should not preclude the use of effective therapies like PTCA and CABG in elderly patients with angina.
Supports revascularization in selected elderly angina patients; leaves open confirmation in randomized trials.
Aging is a physiological process that influences the life span when associated with risk factors such as diabetes mellitus, coronary disease, systemic hypertension, and congestive heart failure. The chronology inherent in aging should not preclude the use of effective therapy in appropriate settings. In the elderly (defined as “of or pertaining to persons in later life” by the Random House Dictionary, unabridged version), the reductions in mortality from pharmacological or therapeutic interventions are often similar. Studies have demonstrated low complication rates and high rates of successful outcomes in elderly persons undergoing percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery. 1
No takes yet. Share an insight, caveat, or question.
Futterman et al. (2007) conducted a review in Angina. Pharmacological or therapeutic interventions (PTCA and CABG) was evaluated. Percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery demonstrate low complication rates and high rates of successful outcomes in elderly persons.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: